2009 -2014 Director, Personalized Cancer Medicine @
2009 -2011 Associate Professor of Medicine, Division of Hematology and Oncology @
2022 -2025 Member, Board of Directors @
2024 -2025 Independent Member, Board of Directors @
2022 -2023 Chief Development Officer, Executive Vice President @
2021 -2023 Co-Founder @ Roche Institute of Translational Bioengineering (renamed the Institute of Human
2018 -2022 Head of Pharma Research and Early Development (pRED); Member, Enlarged Corporate Executive Committee @
2014 -2018 Senior VP, Global Head Oncology Discovery and Translational Area @
2005 -2009 Assistant Member, Human Oncology and Pathogenesis Program @
2004 -2009 Assistant Attending Physician, Thoracic Oncology Service @
now Postdoctoral Fellowship, Harold Varmus Lab, Oncology and Cancer Biology @
now Fellowship, Medical Oncology @
2006 -2009 Assistant Professor of Medicine @
now Medical Resident, Internal Medicine @
William Pao Education
Yale University School of Medicine
Doctor of Medicine (M.D.)
1990-1998
Yale University
Doctor of Philosophy (Ph.D.) (Biology)
1990-1997
Harvard University
Bachelor's Degree (East Asian Studies)
1986-1990
William Pao Summary
William Pao, based in New York, NY, US, is currently a Chief Executive Officer at Revelio Therapeutics, Inc.. William Pao brings experience from previous roles at Susan Wojcicki Foundation, Immunocore, Joan & Sanford I. Weill Medical College of Cornell University and Alentis Therapeutics. William Pao holds a 1990 - 1998 Doctor of Medicine (M.D.) @ Yale University School of Medicine. William Pao has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different William Pao?
Find contact details for 700 million professionals.